echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > National Drug Supervision and Administration Work Video and Telephone Conference Held

    National Drug Supervision and Administration Work Video and Telephone Conference Held

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Medical News, July 27th, July 26th, the national drug supervision and management work video and telephone conference was held
    .
    The meeting was guided by Xi Jinping’s thoughts on socialism with Chinese characteristics for a new era, thoroughly studied and implemented the spirit of General Secretary Xi Jinping’s "July 1st" speech, implemented the deployment requirements of the national market supervision video and telephone conference, summarized the work in the first half of the year, analyzed the situation, exchanged experience, In the second half of the year, the work will be redeployed and then implemented

    .
    Party Secretary Li Li and Director Jiao Hong of the State Food and Drug Administration attended the meeting and delivered speeches

    .
    Members of the Bureau Party Group and Deputy Directors Xu Jinghe, Chen Shifei and Yan Jiangying attended the meeting

    .
    The Director of Drug Safety of the State Drug Administration and the responsible comrades of the Disciplinary Inspection and Supervision Group of the Central Commission for Discipline Inspection and the State Supervision Commission in the State Administration for Market Regulation attended the meeting

    .

    The meeting pointed out that since this year, the national drug regulatory authorities have conscientiously implemented the decisions and deployments of the Party Central Committee and the State Council, resolutely assumed the political responsibility for epidemic prevention and control, and coordinated the work of ensuring safety, promoting development, improving capabilities, and strengthening party building, effectively protecting the people.
    The medicine used by the masses is safe and effective

    .
    The party’s leadership and party building have been strengthened in an all-round way, the study and education of party history have been carried out in a down-to-earth manner, and the strict governance of the party has continued to expand in depth

    .
    New achievements have been made in the overall situation of service guarantee for epidemic prevention and control, and major achievements have been made in ensuring the quality and supply of the new crown virus vaccine, which fully demonstrates the political responsibility and responsibility of the drug regulatory department

    .
    Drug safety and quality supervision has highlighted new results, and the drug safety situation has remained generally stable

    .
    Promote the high-quality development of the pharmaceutical industry to achieve new breakthroughs, and accelerate the listing of innovative drugs, innovative medical devices and children's drugs

    .
    New steps have been taken in the construction of drug regulatory capabilities, and the drug regulatory system and regulatory capabilities are more adapted to the industry development situation and regulatory tasks

    .

    The meeting emphasized that this year marks the 100th anniversary of the founding of the Communist Party of China and the beginning of the "14th Five-Year Plan" period.
    The normalization of epidemic prevention and control has entered a critical stage, and it is of great significance to do a good job in drug supervision in the second half of the year

    .
    We must adhere to the guidance of Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, thoroughly study and implement the spirit of the 19th National Congress of the Communist Party of China and the 2nd, 3rd, 4th, and 5th Plenary Sessions of the 19th Central Committee, and follow the "four strictest" requirements of General Secretary Xi Jinping.
    For the fundamental orientation, based on ensuring safety and keeping the bottom line, promoting development and catching up to the top line, we will do our best to do a good job in the approval and listing of epidemic prevention and control medical devices and quality supervision, control drug safety risks, deepen drug regulatory reform, and accelerate the modernization of drug regulatory systems and regulatory capabilities.
    Effectively guarantee the safe and effective use of drugs for the people, and ensure that the reform and development of drug supervision during the "14th Five-Year Plan" has a good start and a good start

    .

    In his speech, Li Li put forward requirements for six areas of work that need to be focused on in the second half of the year
    .
    First, we must thoroughly study and implement the spirit of General Secretary Xi Jinping's "July 1st" speech, promote deep learning of party history and education, and earnestly transform the learning results into a powerful driving force for the reform and development of drug regulation

    .
    Second, we must do a solid job in ensuring the quality and supply of the new crown virus vaccine, do not relax, do a good job in emergency review and approval, continue to strengthen production supervision, improve the quality and efficiency of batch issuance, strengthen circulation and distribution supervision, and fully serve to ensure the overall situation of epidemic prevention and control

    .
    Third, we must strictly prevent and control drug safety risks, highlight the quality supervision of anti-epidemic drugs, strengthen supervision of key products and fields, improve drug safety emergency management mechanisms, and do a solid job in drug case investigation to ensure a stable drug safety situation

    .
    Fourth, we must promote the high-quality development of the pharmaceutical industry, deepen the reform of the review and approval system, support the inheritance and innovation of traditional Chinese medicine, continue to promote the reform of "delegation, regulation and service", and promote China's leap from a big pharmaceutical country to a strong pharmaceutical country

    .
    Fifth, we must comprehensively strengthen the construction of drug regulatory capacity, earnestly implement the "Implementation Opinions on Comprehensively Strengthening Drug Regulatory Capacity Building" of the General Office of the State Council, improve the drug regulatory system, improve drug management regulations and systems, innovate regulatory methods and methods, strengthen the deployment of regulatory forces, and enhance drugs Regulatory modernization level

    .
    Sixth, we must uphold and strengthen the overall leadership of the party, persevere in improving the work >
    .

    In his speech, Jiao Hong summarized the drug supervision work in the first half of the year and made specific arrangements for the work in the second half of the year
    .
    The first is to provide full service to ensure the overall situation of epidemic prevention and control, ensure the quality and supply of the new crown virus vaccine, and strengthen the quality supervision of epidemic prevention and control medicine equipment

    .
    The second is to resolutely grasp the key to the supervision of high-risk products, insist on overall development and safety, strengthen the investigation and resolution of hidden risks, strengthen the supervision of conventional vaccine varieties, strengthen the supervision of the centralized procurement of selected products by national organizations, and strengthen the supervision of innovative products and enterprises

    .
    The third is to thoroughly implement the concept of high-quality development, continue to improve the review, review and approval system and mechanism, continue to deepen the reform of the drug and medical device review, review and approval system, promote the solution of the "stuck neck" problem of industrial innovation and development, and promote the development of major scientific and technological projects and major new drugs Special research to accelerate the realization of independent controllability of high-end medical equipment, promote the construction of a new development pattern for the pharmaceutical industry, deepen the reform of “delegation, management, and service”, and continue to optimize the business environment

    .
    The fourth is to continuously consolidate the construction of drug regulatory capacity, accelerate the revision of supporting regulations and standards, accelerate the preparation of the "14th Five-Year" plan, in-depth advance regulatory scientific research, and accelerate the advancement of smart supervision

    .
    The fifth is to vigorously strengthen the guarantee of work >
    .
    Establish a “pro-clean” political-business relationship, resolutely oppose formalism and bureaucracy, and ensure that the cause of supervision is advancing courageously with a drug supervision team that dares to meet tough, bears, and benevolent actions

    .

    At the meeting, the main responsible comrades of the drug regulatory authorities in Beijing, Shanghai, Zhejiang, Sichuan, Shandong and other places made exchanges and speeches
    .
    Responsible comrades of various departments and bureaus of the State Drug Administration, comrades in charge of the party and government of all directly affiliated units, members and related comrades of the drug supervision department of various provinces, autonomous regions, municipalities and Xinjiang Production and Construction Corps, and responsible comrades of the four review and inspection sub-centers respectively.
    Participate in the meeting at the venue and branch venues

    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.